Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00731237 · ClinicalTrials.gov registry record
XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 2,517
- Enrollment target
NCT00731237: Completed study, sponsored by Abbott Medical Devices.
NCT00731237 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 2,517 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00731237 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 2,517 participants
- Enrollment target
Study Summary
This trial is to assess physician-determined XIENCE V® EECSS acute performance, deliverability and resource utilization in the catheterization lab during commercial use by various physicians with a range of coronary stenting experience
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,517 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-10 |
What the finished NCT00731237 record still lists
NCT00731237 is an observational study that tracks outcomes without assigning an intervention. Its 2,517 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00731237 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00731237 about?
NCT00731237 is a clinical study titled "XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery". This trial is to assess physician-determined XIENCE V® EECSS acute performance, deliverability and resource utilization in the catheterization lab during commercial use by various physicians with a range of coronary stenting experience
What is the current status of trial NCT00731237?
This trial is currently completed. The enrollment target is 2,517 participants. The study started on 2008-10. Estimated completion is 2009-10.
Who is sponsoring clinical trial NCT00731237?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04142177 · 2,529 participants · NA
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
- NCT00018057 · 2,530 participants · Phase 2
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia